{"id":"W3170530345","doi":"10.1200/jco.2021.39.15_suppl.e14574","title":"Initial results from a first in human trial incorporating accelerated dose titration of a novel immune stimulating oncolytic virus - VG161.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Vancouver Biotech (Canada)","funders":"","keywords":"Oncolytic virus; Medicine; Immune system; Cohort; Tolerability; Adverse effect; Virus; Immunology; Internal medicine; Oncology; Gastroenterology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002000659,0.001224567,0.001298138,0.0002484759,0.0002730182,0.001038054,0.0005427623,0.001284974,0.00350896],"category_scores_gemma":[0.001480669,0.0003588533,0.0008668788,0.0002305049,0.0007186151,0.0006723704,0.000254778,0.002285968,0.000705814],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006970463,"about_ca_system_score_gemma":0.0009077616,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005289899,"about_ca_topic_score_gemma":0.001115271,"domain_scores_codex":[0.9994231,0.0002885934,0.00002779345,0.00008976198,0.00005393148,0.0001167751],"domain_scores_gemma":[0.9991902,0.0002353281,0.0001481562,0.0001024287,0.00006373725,0.0002601357],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5909125,0.0796522,0.005362968,0.001354889,0.001344506,0.0005674704,0.000658872,0.006195042,0.1752122,0.0008931778,0.008542748,0.1293034],"study_design_scores_gemma":[0.1372739,0.834927,0.00755068,0.00005266139,0.0003579322,0.0002797798,0.00005836093,0.001084522,0.01131322,0.0005150989,0.006553622,0.00003329894],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9847845,0.001886619,0.002852348,0.0004961904,0.0002487837,0.004816717,0.002175213,0.0001611405,0.00257853],"genre_scores_gemma":[0.9841058,0.001197144,0.003298162,0.0007131421,0.0001704889,0.003686523,0.002361652,0.00006136789,0.004405745],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00350896,"threshold_uncertainty_score":0.0117386,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2447547933781513,"score_gpt":0.5044252886294944,"score_spread":0.2596704952513431,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}